Biologic Treatments
Targeted Relief
Biologic treatments are revolutionizing the way we approach skin conditions, offering targeted and effective solutions for chronic conditions like psoriasis, atopic eczema, hidradenitis suppurativa and urticaria. These treatments are made from proteins and grown from animal, human, or micro-organic material in a laboratory, designed to tweak specific parts of the immune system rather than suppressing it entirely.
How do Biologics Work
Biologics work by targeting specific areas of the immune system that contribute to skin conditions. This approach allows for rapid improvement in refractory skin conditions, making them especially useful for patients who haven't responded well to traditional treatments
Benefits and Potential Risks
Biologics work generally in a few ways. A targeted approach where biologics focus on specific parts of the immune system, reducing side effects and improving efficacy. A rapid improvement where it rapidly improves skin conditions, providing quick relief for patients. Biologics are particularly useful for managing chronic skin conditions like psoriasis and atopic eczema.
With any treatment, biologics are not without risks. These include but not limited to increased risk of infections: Biologics can make serious infections more likely, as they alter the immune system, recurrence of chronic diseases where biologics may cause a recurrence of some chronic diseases that are in remission. Some health insurance may not cover for the biologic treatments hence it is essential to check with your provider.
Skin Condition can be Treated with Biologics
Biologics treatments are used when traditional treatment has not worked or failed to alleviate the symptoms. These are particular beneficial for skin conditions such as psoriasis, eczema and suppurativa hiradenitis.
Range of Biologics DermDental can provide
TREMFYA® (guselkumab) - for management of chronic plaque psoriasis
STEQEYMA® (ustekinumab biosimilar) - for management of chronic plaque psoriasis
YUFLYMA® (adalimumab biosimilar) - for management of chronic plaque psoriasis and hidradenitis suppurativa
Omlyclo® (Omalizumab biosimilar) - for management of chronic idiopathic urticaria
